Asston Pharmaceuticals Ltd vs Gufic Biosciences Ltd Stock Comparison
Asston Pharmaceuticals Ltd vs Gufic Biosciences Ltd Stock Comparison
Last Updated on: Jun 15, 2026
Key Highlights
The Latest Trading Price of Asston Pharmaceuticals Ltd is ₹ 82.78 as of 12 Jun 15:30
. The P/E Ratio of Asston Pharmaceuticals Ltd is 0 as of March 2024
.The P/E Ratio of Gufic BioSciences Ltd is 33 as of March 2024
. The Market Cap of Asston Pharmaceuticals Ltd is ₹ 0 crore as of March 2024
.The Market Cap of Gufic BioSciences Ltd is ₹ 2839 crore as of March 2024
. The revenue of Asston Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gufic BioSciences Ltd for the Mar '26 is ₹ 250.65 crore as compare to the Dec '25 revenue of ₹ 232.2 crore. This represent the growth of 7.95% The ebitda of Asston Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gufic BioSciences Ltd for the Mar '26 is ₹ 46.04 crore as compare to the Dec '25 ebitda of ₹ 33.77 crore. This represent the growth of 36.33% The net profit of Asston Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0%
The net profit of Gufic BioSciences Ltd changed from ₹ 20.86 crore to ₹ 21.9 crore over 8 quarters. This represents a CAGR of 2.46%
The Dividend Payout of Asston Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gufic BioSciences Ltd changed from 2.19 % on March 2021 to 1.43 % on March 2025 . This represents a CAGR of -8.17% over 5 years .
About Asston Pharmaceuticals Ltd
Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt.
Limited' to contract produce pharmaceutical products for export market.
Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility.
Ferron Lifecare Private Limited, incorporated on 30th January 2020.
Finally, 'Asston Pharmaceuticals Private Limited' was converted into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.
Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.
About Gufic BioSciences Ltd
Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
The Company is ranked among the top 100 pharmaceutical companies in India.
Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
The Company was incorporated in July, 1984.
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.
FAQs for the comparison of Asston Pharmaceuticals Ltd and Gufic BioSciences Ltd
Which company has a larger market capitalization, Asston Pharmaceuticals Ltd or Gufic BioSciences Ltd?
Market cap of Asston Pharmaceuticals Ltd is 70 Cr while Market cap of Gufic BioSciences Ltd is 3,723 Cr
What are the key factors driving the stock performance of Asston Pharmaceuticals Ltd and Gufic BioSciences Ltd?
The stock performance of Asston Pharmaceuticals Ltd and Gufic BioSciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Asston Pharmaceuticals Ltd and Gufic BioSciences Ltd?
As of June 15, 2026, the Asston Pharmaceuticals Ltd stock price is INR ₹82.78. On the other hand, Gufic BioSciences Ltd stock price is INR ₹371.3.
How do dividend payouts of Asston Pharmaceuticals Ltd and Gufic BioSciences Ltd compare?
To compare the dividend payouts of Asston Pharmaceuticals Ltd and Gufic BioSciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.